Rockville, Maryland, January 14, 2022 /PRNewswire/ — Pan Zheng, MD, was named a Distinguished Executive by Continental Who’s Who for her outstanding work in medical research and her work with OncoC4 Inc and OncoImmune Inc.
Dr. Cheng is the co-founder of Oncolmmune Inc and OncoC4 Inc. She has spent her career establishing the safety and efficacy of OncoImmune’s products through Phase II and Phase III clinical trials, as well as pioneering human trials in cancer patients and health research participants. Dr. Cheng is also committed to teaching in many nationally accredited academic institutions.
In 1987, Dr. Zheng studied at Peking Union Medical College and obtained a medical degree. Dr. Zheng then studied at Peking Union Medical College. Yale University,obtain doctoral degree. degree in immunobiology in 1994. She then completed her anatomy and clinical pathology internship at New York University School of Medicine in 1998. After studying clinical and anatomical pathology, Dr. Cheng was board certified by the American Board of Pathology.
Dr Cheng was in Beijing From 1987 to 1989, she worked at Peking Union Medical College Hospital, where she obtained…